189 related articles for article (PubMed ID: 24997604)
21. Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands.
Wootten D; Savage EE; Willard FS; Bueno AB; Sloop KW; Christopoulos A; Sexton PM
Mol Pharmacol; 2013 Apr; 83(4):822-34. PubMed ID: 23348499
[TBL] [Abstract][Full Text] [Related]
22. Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor.
Underwood CR; Knudsen LB; Garibay PW; Peters GH; Reedtz-Runge S
Peptides; 2013 Nov; 49():100-8. PubMed ID: 24045233
[TBL] [Abstract][Full Text] [Related]
23. A β-peptide agonist of the GLP-1 receptor, a class B GPCR.
Denton EV; Craig CJ; Pongratz RL; Appelbaum JS; Doerner AE; Narayanan A; Shulman GI; Cline GW; Schepartz A
Org Lett; 2013 Oct; 15(20):5318-21. PubMed ID: 24087900
[TBL] [Abstract][Full Text] [Related]
24. The identification of novel proteins that interact with the GLP-1 receptor and restrain its activity.
Huang X; Dai FF; Gaisano G; Giglou K; Han J; Zhang M; Kittanakom S; Wong V; Wei L; Showalter AD; Sloop KW; Stagljar I; Wheeler MB
Mol Endocrinol; 2013 Sep; 27(9):1550-63. PubMed ID: 23864651
[TBL] [Abstract][Full Text] [Related]
25. Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.
Li N; Lu J; Willars GB
PLoS One; 2012; 7(10):e47936. PubMed ID: 23094100
[TBL] [Abstract][Full Text] [Related]
26. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
Nakane A; Gotoh Y; Ichihara J; Nagata H
Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
[TBL] [Abstract][Full Text] [Related]
27. Characterization of glucagon-like peptide-1 receptor-binding determinants.
Xiao Q; Jeng W; Wheeler MB
J Mol Endocrinol; 2000 Dec; 25(3):321-35. PubMed ID: 11116211
[TBL] [Abstract][Full Text] [Related]
28. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
29. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).
Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW
J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958
[TBL] [Abstract][Full Text] [Related]
30. The putative signal peptide of glucagon-like peptide-1 receptor is not required for receptor synthesis but promotes receptor expression.
Ge Y; Yang D; Dai A; Zhou C; Zhu Y; Wang MW
Biosci Rep; 2014 Nov; 34(6):e00152. PubMed ID: 25330813
[TBL] [Abstract][Full Text] [Related]
31. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
Roed SN; Nøhr AC; Wismann P; Iversen H; Bräuner-Osborne H; Knudsen SM; Waldhoer M
J Biol Chem; 2015 Jan; 290(2):1233-43. PubMed ID: 25451942
[TBL] [Abstract][Full Text] [Related]
32. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
33. Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1.
Hager MV; Clydesdale L; Gellman SH; Sexton PM; Wootten D
Biochem Pharmacol; 2017 Jul; 136():99-108. PubMed ID: 28363772
[TBL] [Abstract][Full Text] [Related]
34. The structure and function of the glucagon-like peptide-1 receptor and its ligands.
Donnelly D
Br J Pharmacol; 2012 May; 166(1):27-41. PubMed ID: 21950636
[TBL] [Abstract][Full Text] [Related]
35. Isolation and structure-function studies of a glucagon-like peptide 1 receptor from goldfish Carassius auratus: identification of three charged residues in extracellular domains critical for receptor function.
Yeung CM; Mojsov S; Mok PY; Chow BK
Endocrinology; 2002 Dec; 143(12):4646-54. PubMed ID: 12446592
[TBL] [Abstract][Full Text] [Related]
36. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Pyke C; Heller RS; Kirk RK; Ørskov C; Reedtz-Runge S; Kaastrup P; Hvelplund A; Bardram L; Calatayud D; Knudsen LB
Endocrinology; 2014 Apr; 155(4):1280-90. PubMed ID: 24467746
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
Runge S; Thøgersen H; Madsen K; Lau J; Rudolph R
J Biol Chem; 2008 Apr; 283(17):11340-7. PubMed ID: 18287102
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo.
Kim JG; Baggio LL; Bridon DP; Castaigne JP; Robitaille MF; Jetté L; Benquet C; Drucker DJ
Diabetes; 2003 Mar; 52(3):751-9. PubMed ID: 12606517
[TBL] [Abstract][Full Text] [Related]
39. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Diabetes; 2004 Sep; 53(9):2492-500. PubMed ID: 15331566
[TBL] [Abstract][Full Text] [Related]
40. Different role of intracellular loops of glucagon-like peptide-1 receptor in G-protein coupling.
Bavec A; Hällbrink M; Langel U; Zorko M
Regul Pept; 2003 Mar; 111(1-3):137-44. PubMed ID: 12609761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
